4//SEC Filing
Auchincloss Thomas G 4
Accession 0001209191-21-039741
CIK 0001367920other
Filed
Jun 10, 8:00 PM ET
Accepted
Jun 11, 8:37 AM ET
Size
12.0 KB
Accession
0001209191-21-039741
Insider Transaction Report
Form 4
Auchincloss Thomas G
Director
Transactions
- Award
Stock Option (right to buy)
2021-06-10+10,250→ 10,250 totalExercise: $4.26Exp: 2031-06-09→ Common Stock (10,250 underlying) - Award
Common Stock
2021-06-10+5,125→ 11,625 total
Footnotes (3)
- [F1]Represents a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. These RSUs vest in full on the earlier of (i) June 10, 2022 and (ii) the date that is one business day prior to the date of the Issuer's next annual meeting of stockholders. The amount listed represents the maximum number of shares of Common Stock of the Issuer that may be delivered pursuant to the grant.
- [F2]Not applicable.
- [F3]The shares underlying this option vest in equal quarterly installments over a one-year period through June 10, 2022, provided that such option shall vest in full on the date that is one business day prior to the date of the Issuer's next annual meeting of stockholders (if earlier than June 10, 2022).
Issuer
CONCERT PHARMACEUTICALS, INC.
CIK 0001367920
Entity typeother
Related Parties
1- filerCIK 0001377820
Filing Metadata
- Form type
- 4
- Filed
- Jun 10, 8:00 PM ET
- Accepted
- Jun 11, 8:37 AM ET
- Size
- 12.0 KB